MICHAEL CARSON: Open Payments
NPI 1477999282 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 108 payments from 19 companies in 2025. Trend: 2023 $2,270 · 2024 $1,761 · 2025 $1,867
Food & beverage: $1,867
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $384 |
| ABBVIE INC. | 20 | $309 |
| PFIZER INC. | 14 | $214 |
| Amgen Inc. | 12 | $198 |
| Novo Nordisk Inc | 12 | $186 |
| Lilly USA, LLC | 8 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
Products named: AIRSUPRA, QULIPTA, OTEZLA, NURTEC ODT, VRAYLAR, Ozempic, BREZTRI, CAPLYTA.
Industry payments across AR — which companies pay providers there.
